Skip to main content
. 2016 Dec 27;8(12):19443–19454. doi: 10.18632/oncotarget.14305

Table 1. Demographic and clinical characteristics of the study sample according to coronary arteriography.

Variable Total (n=186) The results of coronary arteriongraphy P Value
Non-CAD (n=63) (Stenosis <50%) CAD (n=123) (Stenosis ≥50%)
Age, y 67.4±11.6 62.7±10.7 69.7±11.3 0.000
Gender (male), % 56.5 (105/186) 44.4 (28/63) 62.6 (77/123) 0.018
Smokers, % 28.5 (53/186) 19.0 (12/63) 33.3 (41/123) 0.410
Alcohol consumers,% 15.6 (29/186) 17.5 (11/63) 14.6 (18/123) 0.615
Diabetes mellitus, % 27.4 (51/186) 15.9 (10/63) 33.3 (41/123) 0.015
Hypertension, % 62.9 (117/186) 47.6 (30/63) 70.7 (87/123) 0.002
NYHA class III or IV, % 33.3 (62/186) 28.6 (18/63) 35.8 (44/123) 0.324
Lipid drugs medication, % 83.3 (149/186) 71.4 (45/63) 89.4 (110/123) 0.002
Blood glucose, mmol/L 5.51±1.71 5.28±1.48 5.62±1.82 0.065
Serum creatinine, umol/L 93.0±25.4 82.0±18.3 98.6±26.8 0.000
Blood urea nitrogen, mmol/L 6.02±2.25 5.69±2.21 6.19±2.25 0.121
cardiac troponin I, ng/L 1.60±8.50 0.17±0.83 2.35±10.43 0.000
Myoglobin, μg/L 90.4±369 25.6±13.6 123.6±450.7 0.000
CK-MB, IU/L 28.5±61.7 16.1±6.0 34.9±75.0 0.282
Total cholesterol, mmol/L 4.23±1.06 4.50±0.99 4.08±1.07 0.008
LDL cholesterol, mmol/L 2.64±0.89 2.82±0.77 2.54±0.94 0.019
HDL cholesterol, mmol/L 1.09±0.3 1.14±0.27 1.06±0.32 0.023
Serum triglycerides, mmol/L 1.61±1.03 1.69±1.27 1.56±0.88 0.903
Apolipoprotein A1, g/L 1.08±0.16 1.11±0.16 1.06±0.20 0.033
Apolipoprotein B, g/L 0.86±0.22 0.87±0.22 0.85±0.23 0.400
Apolipoprotein A1/B 1.38±0.40 1.39±0.36 1.37±0.42 0.599
Paraoxonase1 activity, U/L 351±123 380±133 336±115 0.026

Values are expressed as mean ± standard deviation or percentage